As this was a pure prophylactic trial , only euthymic bipolar I and II patients ( DSM-IV ) were randomly assigned in a 1:1 ratio to gabapentin ( N = 13 ) or placebo ( N = 12 ) added to the current treatment ( lithium , valproate , carbamazepine , or any combination but not antipsychotics or antidepressants ) .
